Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Ticker SymbolSTVN
Company nameStevanato Group SpA
IPO dateJul 16, 2021
CEOMr. Franco Stevanato
Number of employees5521
Security typeOrdinary Share
Fiscal year-endJul 16
AddressPiombino Dese (Pd) Via Molinella, 17
CityPIOMBINO DESE
Stock exchangeNYSE Consolidated
CountryItaly
Postal code35017
Phone390499318173
Websitehttps://www.stevanatogroup.com/
Ticker SymbolSTVN
IPO dateJul 16, 2021
CEOMr. Franco Stevanato
A total of
53.45M
USD has been distributed in dividends over the past 5 years.
STVN.NB Final Cash Dividend of gross EUR 0.053 paid on Jul 15, 2024 going ex on Jun 04, 2024
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2023 going ex on Jun 07, 2023
STVN.NB Final Cash Dividend of gross EUR 0.051 paid on Jul 13, 2022 going ex on Jun 13, 2022